Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Research and Development
4.1.1.2. Increasing Prevalence of Cancer Cases
4.1.2. Restraints
4.1.2.1. Lack of Skilled Professionals
4.1.2.2. Side Effects
4.1.3. Opportunity
4.1.4. Impact Analysis

5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis

6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before the COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or a Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion

7. By Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
7.1.2. Market Attractiveness Index, By Type Segment
7.2. External Beam Radiation Therapy
7.2.1. Introduction
7.2.2. Market Size Analysis, Us$ Million, 2021-2029 And Y-O-Y Growth Analysis (%), 2021-2029
7.2.2.1. By Product
7.2.2.1.1. Compact Advanced Radiotherapy Systems
7.2.2.1.1.1. Cyberknife
7.2.2.1.1.2. Gamma Knife
7.2.2.1.1.3. Tomotherapy
7.2.2.1.2. Proton Therapy Systems
7.2.2.1.3. Conventional Radiotherapy Systems
7.2.2.2. By Technology
7.2.2.2.1. Image-Guided Radiotherapy (Igrt)
7.2.2.2.2. Intensity Modulated Radiotherapy (Imrt)
7.2.2.2.3. Stereotactic Technology
7.2.2.2.4. Proton Beam Therapy
7.2.2.2.5. 3d Conformal Radiotherapy (3d Crt)
7.2.2.2.6. Others
7.2.2.3. By Application
7.2.2.3.1. Prostate Cancer
7.2.2.3.2. Breast Cancer
7.2.2.3.3. Lung Cancer
7.2.2.3.4. Colorectal Cancer
7.2.2.3.5. Others
7.3. Internal Radiation Therapy/ Brachytherapy
7.3.1. Introduction
7.3.2. Market Size Analysis, Us$ Million, 2021-2029 And Y-O-Y Growth Analysis (%), 2021-2029
7.3.2.1. By Product
7.3.2.1.1. Implants & Applicators
7.3.2.1.2. Electronic Brachytherapy
7.3.2.2. By Technology
7.3.2.2.1. Low Dose Rate
7.3.2.2.2. High Dose Rate
7.3.2.3. By Application
7.3.2.3.1. Prostate Cancer
7.3.2.3.2. Gynecological Cancer
7.3.2.3.3. Breast Cancer
7.3.2.3.4. Others
7.4. Systemic Radiation Therapy
7.4.1. Introduction
7.4.2. Market Size Analysis, Us$ Million, 2021-2029 And Y-O-Y Growth Analysis (%), 2021-2029
7.4.2.1. By Product
7.4.2.1.1. Iobenguane (I-131)
7.4.2.1.2. Samarium-153
7.4.2.1.3. Rhenium-186
7.4.2.1.4. Other Systemic Radiotherapy Products
7.4.2.2. By Type
7.4.2.2.1. Intravenous Radiation Therapy
7.4.2.2.2. Oral Radiation Therapy
7.4.2.2.3. Installation Radiation Therapy

8. By End User
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
8.1.2. Market Attractiveness Index, By End User Segment
8.2. Hospitals and Clinics
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Cancer Research Center
8.4. Other

9. By Region
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. The U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. The U.K.
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Benchmarking

11. Company Profiles
11.1. Accuracy Incorporated
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Varian Medical Systems
11.3. Elekta AB
11.4. IBA (Ion Beam Applications)
11.5. Nordion, Inc.
11.6. Isoray Medical, Inc.
11.7. Research Laboratories AB
11.8. Mevion Medical Systems, Inc.
11.9. Mitsubishi Electric Corporation
11.10. GE Healthcare(*LIST NOT EXHAUSTIVE)

12. DataM Intelligence
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us